Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edema
Not Applicable
Completed
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000015873
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients treated with photocoagulation, anti-VEGF drugs or steroids to intraocular within 6 months 2)severe ketosis, diabetic coma within 6 months 3)severe infection, before operation, severe trauma 4)severe hepatic dysfunction 5)Patients who use of insulin, GLP-1 receptor agonist or diuretic 6)pregnacy 7)Allergy for sitagliptin, nateglinide,liraglutide and exenatide 8)Patients judged by the investigator to be ineligible for some other reason .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method